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Abstract
In this paper we develop a theoretical frame to understand self-regulation of
aneuploidy rate in cancer and stem cells. This is accomplished building upon
quasispecies theory, by leaving its formal mathematical structure intact, but by
drastically changing the meaning of its objects. In particular, we propose a
novel definition of chromosomal master sequence, as a sequence of physically
distinct whole or fragmented chromosomes, whose length is taken to be the
sum of the copy numbers of each whole or fragmented chromosome. This
fundamental change in the functional objects of quasispecies theory allows us
to show that previously measured aneuploidy rates in cancer populations are
already close to a formally derived aneuploid error threshold, and that any
value of aneuploidy rate larger than the aneuploid error threshold would lead to
a loss of fitness of a tumor population. Finally, we make a phenomenological
analysis of existing experimental evidence to argue that single clone cancer
cells, derived from an aneuploid cancer subpopulation, are capable of
self-regulating their aneuploidy rate and of adapting it to distinct environments,
namely primary and metastatic microenvironments. We also discuss the
potential origin of this self-regulatory ability in the wider context of
developmental and comparative biology and we hypothesize the existence of a
diversification factor, i.e. a cellular mechanism that regulates adaptation of
aneuploidy rates, active in all embryo, adult and cancer stem cells.
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Introduction
In normal cells the number of chromosomes and the total DNA
content depends on the phase of the cell cycle1. Non-diploid chromosome content, also known as aneuploidy, is instead the most common feature of human tumor cells2–4. This feature of tumor cells
is commonly associated with acquired resistance to various kinds
of treatments such as radio- or chemotherapy2–5. Nonetheless, it is
not completely clear whether aneuploidy per se contributes to and
drives tumor development, or if instead it is deleterious. In fact,
individuals carrying an extra copy of chromosome 21 have a 50%
lower probability of developing solid tumors than do individuals
with the correct chromosome number6,7 and although aneuploidy is
compatible with organism and cell viability, the presence of additional copies of chromosomes decreases the overall cellular fitness8.
What is clear is that chromosomal instability, i.e. the tendency to
gain or lose parts of the genome during cell replication, seems to
give an advantage to tumor cells9, and clonal heterogeneity within
tumors is one of the main causes of tumor dormancy and resistance
to anti-cancer therapies5,10. Indeed, it has been demonstrated that
even a small population of cells derived from a single cancer cell
clone (diversified population from a single cell), could be responsible for drug resistance and, upon removal of the drug, the population spontaneously reverted to a sensitive state11,12.
The development of single-cell sequencing techniques13 has recently allowed a wide range of studies analyzing chromosomal variability in primary and metastatic tumor cells, as well as healthy
tissues14,15. In particular in Navin et al.16 it is shown that metastatic
tumors are likely to be the product of single clones proliferating
from the primary tumor by observing the microvariation of the integer copy number of consensus sequences in individual tumor cells
through single-cell sequencing.
In this paper we are concerned with measurable changes in the
aneuploid heterogeneity of populations, due to different levels of
chromosomal instability, and to emphasize even more the close link
between aneuploidy and chromosomal instability. We will refer
to the latter as aneuploidy rate, formally defining aneuploidy rate
as the average probability that there is at least one new aneuploid
modification per chromosome during cell replication. We will demonstrate in the Discussion that simple and verifiable statistical consequences of the findings of Navin et al.16 are logically bound to
imply the following proposition.
Adaptive Aneuploidy in Cancer Cells: Single clone cancer cells
derived from an aneuploid cancer subpopulation are capable
of adapting their aneuploidy rate and display distinct aneuploid
rates in distinct environments, namely primary and metastatic
microenvironments.
The full impact of this proposition hinges on the potential ability
to harness adaptive aneuploidy and potentially alter the aneuploidy
rate of cancer cells. The theoretical frame for such a program can
be built on quasispecies theory, a general evolutionary model for
error-prone self replicative systems17, first introduced by Eigen18.
The potential relevance of quasispecies theory to cancer biology
has already been suggested19,20 but unlike previous attempts20–26,
we do not recommend in this paper alternative, structurally diffnt

quasispecies models of cancer cell subpopulations dynamics.
Instead, after a quick review of the relevant elements of standard
quasispecies theory, we note the limits of this theory for the study
of eucaryotic cells, and show that only by defining a novel notion
of chromosomal master sequence it is possible to radically shift
the whole standard quasispecies theory to a new categorical context (i.e. the scenario of cell populations with variable aneuploidy
rates) and properly justify a valid aneuploid quasispecies theory.
This new context allows us to predict (similarly to what the standard quasispecies theory does for single base error rates) a maximal
aneuploidy rate, an error threshold, after which each cancer subpopulation loses its identity, and therefore its ability to pass on its
selectively advantageous genetic traits to future cell generations,
which is referred to as error catastrophe27.
Finally, in the Discussion we perform a phenomenological analysis
of some especially illuminating single cell analysis experiments,
from Navin et al.16, that seem to support our proposition on the
existence of adaptive aneuploidy in cancer cells. We then speculate on
the possible biological basis of self-regulation of aneuploidy rates
in cancer cells. Such refined ability is unlikely to be the product of
a single, specific tumor evolutionary history, rather, we will argue
that embryo and adult stem cells already display very finely regulated rates of aneuploidy, suggesting that a common cellular mechanism of adaptation of aneuploidy is at play, a diversification factor,
which is possibly reactivated in cancer stem cells.

Aneuploid quasispecies
The quasispecies framework
As noted in the Introduction, we need to redefine the main quantities at play in quasispecies theory to make it an appropriate ground
for the biology of aneuploidy, and we begin by briefly sketching the
argument that leads to the error threshold inequality.
The concept of quasispecies was first introduced by Eigen18,28, and
it is a powerful way to relate the structure of population dynamics
to the error rate of single base replication in viruses or unicellular
organisms27,29. The most important consequence of the theory is that
it is possible to determine theoretically a threshold on the error rate
such that, if the error rate of replication of genomic sequences is
pushed above the threshold, the subpopulation will not be able to
retain its identity, for a wide range of models for fitness distribution
in the population (cf. Schuster30, page 81).
Assuming there are N subpopulation types within a population, we
start by writing down the differential equation that describes the
rate of change dxm of type m in terms of the instantaneous size xk(t),
k = 1, ..., N of all types:

dxm
(1)
= (Wmm − E (t )) xm (t ) + ∑ Wmk xk (t ),
dt
k ≠m
						 
Wmm is the rate of effective excess production of sub-population type
m, and if we consider the genetic sequence associated to type m, we
can write Wmm = QmmAm − Dm, with Qmm the probability of precise
reproduction of sequence m, Am the growth rate of type m, and Dm
its mortality rate. Ē(t) = Σk Ek xk is the average, over all types, of the
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excess reproduction rate, with Ek = Ak − Dk and, finally, Wmk is the
rate of production of type m by erroneous reproduction of type k.
Assuming a steady state in which dxm/dt = 0 and neglecting in first
approximation the contributions Σ k≠m W mk x k(t), it is possible to
derive a condition that constrains the probability of precise reproduction of sequence m:

σ mQmm > 1,

(2)

where σ̄m = Am/(Dm + Ēk≠m), with Ēk≠m= Σk≠m Ek xk, is the average superiority of a master sequence associated to a dominant subpopulation
versus competitor sequences, essentially, σ̄m is an index of relative
fitness27. If a master sequence has length vm, and we denote by q̄ the
average fidelity of single nucleotide reproduction, then Qmm = q̄vm
and the error threshold can be written as

l nσ m
≥1 − q .
vm

(3)

Remarkably, Equation 3 establishes a phase transition on the
information content; if the error rate of single nucleotide reprolnσ̄
duction goes above —
the information contained in the master
v
sequence will disintegrate, in the sense that the loss of information
in the sequence due to reproduction errors will not be compensated
by a sufficiently high fitness relative to other subpopulations and the
subpopulation associated to the master sequence will implode27,30.
m

m

Limitations of quasispecies theory in eucaryotic cells
In complex organisms, the quasispecies model is potentially
applicable only in specific scenarios, such as competition among
embryo stem cells during development, adult stem cells and progenitor cells proliferation, and, crucially, cancer cells, where subpopulations compete with each other under limited resources and
changing environment. However, the applicability of the basic
quasispecies model, originally devised in the setting of virus RNA
replication, has been put into question as appropriate for eucaryotes
and specifically for cancer cells. Eucaryotic cells reproduce semiconservatively meaning that the parental double strand degenerates
in the process of generating two daughter double strands, which
led to Brumer et al.21 to raise the possibility that, for high enough
replication error rates, the master sequence, seen here as the double strand of DNA, would eventually disappear, and they suggested
more refined quasispecies models that take into consideration this
phenomenon.
Even more seriously, the applicability of quasispecies theory to
human cells is put into question by the exceedingly high size of
the human genome as compared to RNA viruses. In fact, in order
for the quasispecies not to undergo genetic drift, the neutral space
around a fitness peak should be sufficiently small to be completely
explored by the population. The complexity and the inherent mutational and phenotypical robustness of the human genome amplifies
its neutral space, preventing quasispecies evolution even at higher
than normal mutation rates, as it is the case in cancer cells31. This

fact, together with very low single nucleotide errors for humans,
implies that the fitness of mutants of an hypothetical master
sequence does not change significantly, and the fitness distribution
of mutants around the master sequence is likely to decay linearly, or
sub-linearly, a scenario under which no error threshold is possible30.
Indeed, the existence of Lynch syndrome or hereditary nonpolyposis colorectal carcinomas (HNPCC), which are characterized
by a higher risk of colon cancer, show the inability of the basic quasispecies theory to predict the maximum single nucleotide error that
is viable for a tumor. HNPCC tumors, as well as all microsatellite
instable (MSI) colon cancers, arise because of a break down of the
mismatch repair mechanism32,33. Therefore, MSI cancer cells display increased error rates of single nucleotide replication by 1 to 3
orders of magnitude, with respect to the baseline single nucleotide
error rate 1 − q̄ in healthy cells, estimated to range between 10−9
and 10−10 for the human genome (see Alberts et al.34, page 271, and
Gundry & Vijg35, Lange et al.36 and Jiricny37).
Now recall that the human genome has roughly 3.2 × 109 nucleotides (see Alberts et al.34, page 206), and note that for organisms
with very large genomes, the relative superiority σ̄m of a master
sequence associated to a given subpopulation cannot be very large
(vis a vis other subpopulations), as any given mutation will only
affect its fitness marginally27, and therefore σ̄ m ≈ 1. Given these
numerical estimates, according to the error threshold inequality in
Equation 3, MSI tumors would fail to satisfy the error threshold
inequality to such an extent that they should not even exist. This
is true even if we restrict our attention, in defining the master
sequence, to conserved DNA, i.e. the 5% of the human genome that
is known to be coding and essential to cell function (see again Alberts
et al.34, page 206).

Chromosomal master sequences and aneuploid error
thresholds
We believe that the inconsistences of the basic quasispecies model,
when applied to human cells, completely disappear if we replace
single nucleotide errors with aneuploidy errors. Notably, in all scenarios where quasispecies theory could potentially apply, i.e. stem
and progenitor cells proliferation and cancer cells, aneuploidy rates
far exceed single nucleotide error rates in frequency and impact on
the cell. This means the leading cause in the evolution of a population will be the aneuploidy error, rather than the single nucleotide
error, which can be neglected, especially when the mismatch repair
genes are intact as happens in the overwhelming majority of cancers and all healthy stem cells.
We need now to reinterpret the notion of reproduction fidelity of a
sequence adequately to properly define error thresholds in the presence of aneuploidy. Since we can neglect nucleotide errors, we
assume a faithful reproduction of the genetic material when the copy
number of each chromosome in a sequence (two, for example, in a
diploid cell) is kept constant during replication, both numerically
(number of physically distinct whole chromosomes or fragments)
and structurally (translocations, deletions and amplifications of
DNA). Although complex aneuploidy landscapes may arise, characterized by concurrent numerical and structural chromosomal
changes, most of the somatic copy-number alterations (SCNAs)
Page 3 of 12

F1000Research 2013, 2:268 Last updated: 10 MAR 2014

frequently found in tumor cells involve whole chromosomes or
whole-arms (25% of the genome), with only 10% of the cancer cell
genome being affected by focal SCNAs9,38,39.
Therefore, we now make a series of definitions consistent with
these arguments, whose objective is to change the domain of
applicability of quasispecies theory, without altering its formal
mathematical structure:
Chromosomal Master Sequence. A chromosomal master sequence
is the collection of physically distinct whole and fragmented
chromosomes in the cell.
Chromosomal Master Sequence Length. The chromosomal master
sequence length cm of a cell is the sum of the copy numbers of
each whole or fragmented chromosome in its nucleus.
Aneuploid Fidelity. The aneuploid fidelity Ām is the average
probability that each whole or fragmented chromosome is reproduced
exactly once in cell division, with no gain or loss of sub-chromosomal
regions.
In this aneuploid scenario, the chromosomal master sequence
length cm can fluctuate depending on the number of aneuploid copies of whole chromosomes or fragments, and the underlying nucleotide sequence will clearly differ according to which chromosomes
or individual genes are affected by copy-number alterations in each
cell. Although tumors vary widely in the number and type of copy
number changes, most of these comprise low-level alterations and
only a few genes reach more than 20 copy numbers, mainly due to
their oncogenic or drugresistance functions16,40–42.
Aneuploid events can cause large phenotypical variations ,
even a single error leading to chromosomal loss or addition can
have large effects, therefore the fitness distribution around a master sequence is expected to display a sharp decay from the master
sequence peak, in line with the types of fitness distribution known
to express the error threshold30. At least for cancer cells, subpopulations are sharply defined in terms of their aneuploid profile,
as evinced from single cell analysis works16 commented in the
Discussion. This is further evidence of the strong concentration of
fitness distributions around a few chromosomal sequence types.
43–46

Mutants of the master sequence, generated by even a single aneuploid
error, and individual cells belonging to other sub-populations, are
exceedingly unlikely to be able to mutate into cells expressing the
master sequence, since any additional (erroneous) chromosome copy
is subject to a wide variety of further partial deletions/additions, and
only very few of them would correspond to a return to the master
sequence configuration. Essentially, we can assume that the contribution of cells belonging to other subpopulation types to the dynamical evolution of the master sequence subpopulation is very small.
This is exactly the condition that led to the error threshold in the first
place, since Equation 3 is derived as a limiting stationary behavior
of an interacting family of subpopulations described by Equation 1,
where the rate of growth of each of them is weakly affected by the
cross-mutations derived from the other subpopulations27,30.

Given these caveats regarding distribution of fitness for chromosomal master sequences in the presence of aneuploidy and regarding
sub-population interactions, we reach the conclusion that quasispecies theory is indeed applicable to cancer and stem cells, but only in
the context of aneuploid chromosomal master sequences, neglecting the underlying nucleotide errors.
We can now replace variables in the error threshold inequality in
Equation 3 to take into account not only the varivariable length cm
of the chromosomal master sequence associated to all whole and
fragmented chromosomes, but also the correction to the probability
Qmm of precise reproduction of a sequence that aneuploidy entails.
The probability of precise reproduction of a specific sequence of
chromosomes m can be expressed as Qmm = Ācmm, and the aneuploid
error threshold inequality can be written as σ̄mĀcmm > 1, which eventually gives us a standard form (formally identical to Equation 3) for
the aneuploid error threshold inequality:

lnσ m
≥1 − Am ,
cm

(4)

However each term in this equation has drastically different
orders of magnitudes than the threshold inequality for DNA or RNA
master sequences. To start with, as already stressed above, the relative superiority σ̄m will have considerable fluctuations, since the
chromosomal master sequence is much shorter than a nucleotide
sequence, and even small variations in copy numbers can effect large
phenotypical variations.
At the same time, the diversity of subpopulations in primary
tumors16,47–51 implies that, in a fully developed tumor, different subpopulations do not have extremely different relative superiority σ̄m,
a scenario that would lead to a single, highly dominant subpopulation.
It is therefore reasonable to assume at the very most σ̄m ∈ [102, 103],
for the subpopulations of highest relative superiority. We know
moreover that highly aneuploid tumors have higher fitness52, so
larger values of σ̄m are likely to be associated with large values of
cm, up to the order of 10213,39,53,54.
Let Em = 1 – Ām, with Em denoting the aneuploidy error rate, i.e.
the average probability that there is at least one new aneuploid
defect for each chromosome or fragment of chromosome during
cell replication. If we call T(Em) the threshold aneuploidy error rate
above which a chromosomal master sequence is not viable, and if
we take σ̄m ∈ [102, 103], cm ≈ 102, then Equation 4 gives T(Em) ≈ 10–2,
which is consistent with the estimates of Em for cancer cells, in the
range [10–3, 10–1]3,55–58. Our argument implies that the more a cell is
aneuploid, the tighter the error threshold bound is, and that highly
aneuploid cancer cells, known to be most adaptable5,52,59,60, are
already working with aneuploid error rates close to the limit of a
viable quasispecies.
There is some evidence that indeed aneuploidy rates in the tumor
can affect the prognosis of cancer patients9,61. It is suggested that
a moderate tumor aneuploidy rate worsens the prognosis, while a
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very high aneuploidy rate is associated with improved patient outcomes9, consistent with the quasispecies and error threshold catastrophe approach.

study was that the metastasis proliferated from a single cell derived
from the aneuploid subpopulation of the primary tumor, since no
pseudodiploid cancer cells were observed in the metastatic tumor.

Discussion

Other recent studies on myeloproliferative disorders62 and melanoma54,
kidney47,48 and pancreas49 tumors or, again, in breast cancer50, arrived at similar conclusions, pointing to a late, metastasis-specific diversification of primary tumor-derived cells (see Wu et al.63,
Figure S14, and Clifford64). The presence of aneuploid cells in most
primary tumors examined in Gerlinger et al.49, is well documented
by ploidy analysis (see supplementary Figure 10 in their paper) and
metastases show a marked increase in allelic imbalance as compared to primary tumor regions. The authors conclude that tumor
heterogeneity is probably driven by aneuploidy and that chromosomal aberrations contribute substantially to genetic intratumor
heterogeneity. Notably, even in an evolutionary context where the
primary tumor and the metastasis share most of the sequenced
regions, there is a striking variation in copy number specifically in
the metastatic counterpart (see ref.54, Figures S5 to S11 in Lengauer
et al.54). This concept is best exemplified in ref.16, but there, both
the coarse ploidy distribution analysis and the refined, single cell
copy number count for primary and metastatic tumors, drive us to
an additional conclusion: the genetic variability of the aneuploid
clone in the metastasis is greater than its corresponding variability
in the primary tumor from which it came. Even if we took into
account a parallel progression model as opposed to a punctuated or
linear evolution model51,65, the final result would not change. The
metastatic population described in Navin et al.16 has diversified
more than its parental population in the primary tumor, regardless
of whether the metastasis developed in a later, much shorter time
than the primary tumor, or whether its origins date back to the first
stages of primary tumor dissemination. This higher diversification
of the metastatic population holds even though the aneuploid cells’
compartment in the primary tumor does not represent a minority of
the population, and has expanded considerably at some point during
the tumor evolution history.

We would like to revisit and comment upon some specific experimental evidence for our proposal of a self-regulated aneuploidy rate
in cancer cells, focusing on several measures of aneuploidy rate,
and showing how the variability observed in tumor subpopulations
subject to distinct micro-environments can be given a far-reaching
interpretation. Our analysis is phenomenological, meaning that we
explain and reinterpret existing experimental work, showing how
the inner logic of our argument can severely constraint the causes
and interpretation of the data we review. We chose to first perform
an in-depth analysis of a single recent study16, so that the flow of
our discourse is unified and made coherent by constant reference to
the same context. At the same time, we support our arguments with
related experimental works, when appropriate.
The in-depth analysis and commentary of the literature that we perform here is meant to show that there is rigorous, logically compelling,
and experimentally testable biological evidence for the usefulness of
an aneuploid quasispecies theory. Indeed, we argue that it is possible to envision a precise, and functionally in-built mechanism
of self-regulation for aneuploidy rates in normal and cancer stem
cells. The evolutionary role and the structure of this self-regulation
mechanism could be studied and conceptualized within the framework we developed for aneuploid quasispecies. At the same time,
any experimental validation of aneuploid quasispecies predictions
on threshold aneuploidy error rates, would be essentially related to
the presence of this self-regulatory mechanism.

Evidence for self-regulation of aneuploidy rates in cancer cells
The main focus and objective of Navin et al.16 was to show that
metastatic tumors are likely to be the product of single clones proliferating from the primary tumor by observing the microvariation
of the integer copy number of consensus sequences in individual
tumor cells through single-cell sequencing. A coarse ploidy distribution of a large number of cells from a breast tumor and one of its
metastasis was plotted in Navin et al.16 (Figure 3a-b in that paper)
as an histogram with respect to the total DNA content. These ploidy
distributions showed, for both primary and metastatic tumors, two
peaks, one around twice and another at four times the total amount
of DNA. This double peaked distribution is accounted by the presence of roughly 50% of normal diploid cells in each tumor tissue
sample. Importantly, whereas in the primary tumor a significant
fraction of the gated normal cells was pseudodiploid, in the paired
metastasis the normal population was likely to derive from the stromal content of the tissue (see ref.16, Figure 4 in their paper).
Navin et al.16 performed very refined measurements of copy number
profiles, across all chromosomes, from a small subset of cells (hundreds) in sections of primary and metastatic tumors and generated
a neighbor-joining tree of these profiles. This analysis showed that
metastatic and primary aneuploid cells were closely related in the
neighbor-joining tree derived from the clustering, and yet they produced clearly distinct subclusters. The conclusion of this single cell

To justify our claim of adaptive aneuploidy, we note that in Figure 4
of Navin et al.16 the Euclidean distances in the neighbor-joining
tree for the aneuploid cells from the metastatic tumor showed much
greater variability than the Euclidean distances for the corresponding aneuploid cells in the primary tumor. We note that these distances were calculated with respect to a common root profile, and
that mutual distances among individual profiles are likely to be ever
greater. Granted that this study dealt with very small sample populations, a closer inspection and analysis of the tightness of the variance of Euclidean distances in the primary tumor subpopulation,
as opposed to the variance of Euclidean distances of the metastatic
tumor subpopulation, would almost certainly reveal a statistically
significant discrimination of the two. Indeed, distances inferred from
their Figure 4 of ref.16 using a Levene test for equality of variance66
suggest a low probability that the underlying distributions of
Euclidean distances for metastatic aneuploid cells and for primary
aneuploid cells have the same variance (p-value ≈ 0.01).
Note, crucially, that even if we assume high experimental noise in
the data, such noise would affect equally both Euclidean distributions
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and the identification of distinct variances for distances of metastatic aneuploidy cells and primary aneuploidy cells would be even
more unlikely to be observed by chance.
The hypothesis of a larger variability of the copy number profiles of
the metastatic subpopulation is also supported by a closer inspection of the tails of the ploidy distributions of primary and metastatic tumor populations analyzed in Navin et al.16. The right-hand
sides of the tetraploid peaks for the metastatic tumor have distinctly
thicker and longer tails than the corresponding tetraploid peaks in
the primary tumor, suggesting greater variability of aneuploidy in
the former. Other works point to a similar conclusion. For example, it has been shown recently that, although sharing most of the
examined somatic single-nucleotide variants, in vitro cultured low
passage melanoma cells have higher copy number variation when
compared to the parental tumor67.
Ploidy distributions, in their simplicity, offer even more scope for
interpretation and testing of the hypothesis that cancer cells have
the ability to self-regulate their aneuploidy rate. Indeed, a single
cell clone could be capable of generating a diverse metastasis either
because of inherent chromosomal instability, or because its rate of
aneuploidy is somehow increased under the stress conditions of a
new tissue embedding.
Let’s assume first that the single clone from the primary tumor has
chromosomal instability. The dispersion of metastatic cells should
not be in any way preferential to such cells (even if their successful
embedding in a tissue may be), so there will be a, possibly small,
subpopulation of cells in the primary tumor with similar or higher
aneuploidy rate than the cell generating the metastasis. This subpopulation of the primary tumor, by its greater aneuploidy rate,
will be more adaptable and likely self-sustaining, and it should be
observable as a long tail in the ploidy distribution of the primary
tumor population. The tail will be much thinner for the primary tumor
than the metastatic tumor, since high aneuploidy rate cells are only
a sub-population of the primary tumor. However, no such long and
thin tail is observed experimentally for the primary tumor in Navin
et al.16. It is still possible, if highly unlikely, that the metastatic cell
is an extreme outlier, with no comparable cells left in the primary
tumor, but then we would see a much more pronounced evolutionary difference between primary and metastatic aneuploid populations than what is observed. This logically implies that the single
metastatic cell clone was not essentially different from its primary
population before starting to proliferate in the new environment.
This argument leaves only one other option: some cancer cells are
capable of altering and self-regulating their aneuploidy rate under
stress, or under changes in the environment. In conclusion, both
ploidy distribution analysis and single cell analysis of Navin et al.16
give strong evidence for the proposition on adaptive aneuploidy in
cancer cells presented in the Introduction, i.e. that single clone cancer
cells derived from an aneuploid cancer subpopulation, adapt
their aneuploid rates in distinct environments, namely primary and
metastatic microenvironments.

A diversification factor
The Discussion, up to now, centered on the inference, from some
experimental results of ref.16 and other published supportive information48,54,63, that metastatic cancer cells have higher aneuploidy
rates than the corresponding original subpopulation of the primary
tumor. We concluded that this differential could only be explained
by assuming an adaptive, self-regulatory cellular response sensitive
to changes in the environment. As much as tumor populations
undergo extensive evolution during their development, it seems
highly unlikely that such a refined property could arise by chance
only in the specific population studied in Navin et al.16, without a
preexisting dormant ability to self-regulation.
Indeed, high levels of aneuploidy are associated with increased
adaptability in plants and yeast68,69, and a certain rate of aneuploidy,
leading to precise percentages of mosaic aneuploidy, is common in
several mammals’ embryos (see van Soom & Boerjan70 chapter 10),
including humans71,72. Similarly, it is speculated that the significant
mosaic aneuploidy in adult human organs such as the liver and
brain is instrumental to an increased plasticity and adaptability of
such organs73,74. Lang et al.75 raise the possibility that the extensive
aneuploidy in the embryo may transfer into similarly widespread
copy number variations in all human tissues.
Observable levels of aneuploidy have been found in adult cells76,
and while this widespread aneuploidy could already originate during embryo development75, adult, non-transformed stem cells continue to have distinct levels of aneuploidy rates according to their
type. For example, mesenchymal stem cells are likely to have very
low aneuploidy rates77, while hepatocytes together with small intestine and pancreas cells display within-tissue extensive copy number
variation (CNV)78,79.
These strikingly different aneuploidy rates among embryo stem
cells and adult stem cells, raise the possibility that the finely tuned,
and distinct, high aneuploidy rates observed in embryos and adult
tissues are regulated by some mechanism specific to stem cells,
rather than being a simple byproduct of aberrant or sustained cell
division. This is a simple, fundamental observation, and yet one
that is rarely emphasized in the literature. We formalize its essence
in a proposition:
Differentially Expressed Aneuploidy in Stem Cells. Embryo and
adult stem cells display finely tuned, and distinct, aneuploidy rates,
unrelated to the replication rates of the stem cells themselves.
And we refer to Section 2 of our preprint ‘Stem-like Adaptive
Aneuploidy and Cancer Quasispecies’ (available at arxiv.org/
pdf/1303.6374.pdf) for a much more thorough review of literature
supporting the idea of a differentially expressed aneuploidy in stem cells.
Since many types of cancers partially inherit the hierarchical structure of the tissues they have derived from and are assumed to be
propagated by stemlike tumor cells80, it is possible that increased
aneuploidy rates are used actively, to the population advantage, to

Page 6 of 12

F1000Research 2013, 2:268 Last updated: 10 MAR 2014

increase the adaptability of stem or fast-dividing progenitor cells. It
is worth noting that, to date and to our knowledge, only two studies assessed the relationship between aneuploidy and cancer stem
cells (CSCs)81,82. In the first paper, Kusumbe and Bapat evaluated
the expression of stem-cell markers and the DNA content distribution of fluorescently labeled ovarian cancer cells after subcutaneous injection into immunodeficient mice. The authors found that,
unlike label-free tumor cells, the label-retaining (quiescent) cells
displayed stem-cell markers and were embedded with a small fraction of aneuploid cells. Treatment with chemotherapy increased the
percentage of quiescent cells in the overall population and selectively stimulated the proliferation of the aneuploid fraction, which
retained stem-like properties upon removal of the drug81. A second
study by Fujimori et al., reveals again that stressful conditions
favor the emergence of CSC-like clones from differentiating embryo
stem cells in in vitro culture82.
And this brings us to the proposition we stated in the introduction
on adaptive aneuploidy in cancer cells: in light of the refined use of
aneuploidy in stem cells, self-regulation of aneuploidy as argued in
this Discussion could be a reactivation, in cancer stem cells, of a
preexisting cellular mechanism common to embryo and adult stem
cells - a diversification factor. Note that the proposition on differentially expressed levels of aneuploidy in normal stem cells is not
compatible with a random, self-catalytic increment of aneuploidy
first suggested in Rasnick & Duesby45, since otherwise we would
not be able to observe consistently similar levels of aneuploidy
within each stem cell type, and among different individuals. Moreover, we would see a correlation between fast replicating stem cells
and levels of aneuploidy in the corresponding tissue. This is not
necessarily the case. For example the percentage of cells undergoing DNA replication in solid tumors, which are mostly aneuploid,
varies between 2% to 8%, whereas a normal renewing epithelium such as the intestine exhibits a DNA replication index of
approximately 16%83.
A random progression of aneuploidy would display much more
pronounced variability within each stem cell class, while the spread
of aneuploidy would be similar in all stem cell classes, and not
differentially expressed in each of them. Note that the theory of
a self-catalytic origin of aneuploidy in principle could be made
consistent with the proposition on adaptive aneuploidy in cancer.
It is only by taking together the proposition on adaptive aneuploidy
in cancer (stem) cells, and the proposition on differentially expressed

aneuploidy in (all) stem cells that we argue the following hypothesis is strongly implied:
A Diversification Factor: There exists a cellular mechanism
that regulates adaptation of aneuploidy rates, active, to different
degrees and in different modalities, in all embryo, adult and cancer
stem cells.

Conclusions
While it was not the main objective of this theoretical paper to
explore the experimental consequences of our hypothesis on adaptive aneuploidy and aneuploid quasispecies, we note that all our
statements are open to, indeed they invite, simple forms of validation, either through single cell analysis or ploidy distribution
analysis. Elucidating the mechanisms underlying self-regulation of
aneuploidy rates in stem cells under specific microenvironmental
stresses, would provide crucial insight into the developmental and
evolutionary processes of complex organisms.
Finally, we emphasize that validation of the hypothesis that stem
cells can adapt their aneuploidy rate through a diversification factor would have significant therapeutical implications, when specialized to cancer stem cells. Indeed, it would provide a biological way,
mostly inactive or less sensitive in healthy adult cells, to induce an
aneuploid quasispecies error catastrophe to weaken cancer populations, a long held hope that may yet prove itself true.
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In this interesting opinion article, Napoletani et al. attempt to apply the quasispecies theory to the
evolution of anueploidy in cancer. This article proposes some interesting points that attempt to address
the origin of genetic heterogeneity in tumors. An important claim made therein is that aneuploidy is likely
to be the major source of genetic heterogeneity in later stages of tumor development particularly when
compared to the rate of individual DNA mutations. Further, the authors also posit that cancer cells must
maintain a given rate of chromosome missegregation beyond which a meltdown occurs.
I think this article is acceptable, but feel the authors should address the following points:
Please change the "aneuploidy rate" into "chromosome mis-segregation rate" or something of that
nature. Aneuploidy by definition is a state and not a rate. What the authors imply is "the rate of
change in aneuploid karyotypes which is synonymous to chromosome mis-segregation (which
includes whole chromosome missegregation as well as partial i.e. translocation etc...)
It is important throughout the article to make the distinction between tolerance for aneuploidy in
normal vs. cancer tissues. While evidence suggests that aneuploidy may lead to cellular stress in
normal tissues, it is unclear whether this is the case in cancer cells. Either cancer cells
preferentially maintain aneuploidy at the expense of increased cellular stress and slower
proliferation rate or they might instead have also evolved to overcome cellular stress in response to
aneuploidy. Furthermore, constitutional aneuploidy (for instance in individuals with trisomy) may
have gone through a stem-cell adaptation phase that is different when compared to cancer cells
who acquire aneuploidy de novo.
The concept of error catastrophe is very interesting and rather important in the field of aneuploidy
and chromosome segregation. I would encourage the authors to further elaborate on the optimal
T(Em) value being near 10-2. Can the authors use the quasispecies model to make predictions for
the fitness of the tumor cell populations if the T(Em) values were much higher? This would be
extremely valuable.
In addition to chromosome segregation errors (which include whole and partial chromosome copy
number changes) it would be useful to incorporate the newly uncovered massive rearrangements
known as chromothripsis and chromoplexy. In some cases, these massive rearrangements can
lead to double minute chromosomes carrying oncogenes that are present in hundreds of copies (a
lot higher than the maximum rate of 20 copies for any given gene that the authors presume). The
authors do not account for these possibilities in their model.
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A concept that the authors bring up is the presence of a feedback loop from the environment that
can "fine tune" chromosome segregation. While there is no data to necessarily refute this
assumption, this reviewer believes that it is not currently supported by experimental data. What is
much more likely is that mis-segregation rates occur somewhat independently and aneuploid cells
are under constant selection in vivo which may ultimately favor cells that have a given
missegregation rate to become more viable under certain conditions.
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The authors emphasize in their introduction to the present paper that: “The theoretical frame to
understand such self-regulation resides with quasispecies theory”, however, they introduce a change in
its definition or the meaning of its objects. In particular, they propose a novel definition of the
chromosomal master sequence. Finally, they discuss the potential origin of this self-regulatory ability in
the wider context of developmental and comparative biology with emphasis on a putative “diversification
factor”, defined as a cellular mechanism regulating the adaptation of aneuploidy rates, which is active in
all embryonic and adult cells, as well as cancer stem cells. Furthermore, they refer to literature asserting
that single clone cancer cells derived from an aneuploid cancer subpopulation, are capable of adapting
their aneuploidy rate, and they display distinct aneuploid rates in distinct environments, namely primary
and metastatic microenvironments.
This literature survey indicates that embryonic and adult stem cells display finely tuned, and distinct,
aneuploidy rates, which are unrelated to the replication rates of the stem cells in question. Since many
types of cancer cells partially inherit the hierarchical structure of the tissues from which they emanate, and
are hypothesized to develop from stem like tumor cells, it seems highly probable that increased
aneuploidy rates are used as an advantage to a given cell population, e.g. to increase the adaptability of
stem or fast-dividing progenitor cells.
In this article the authors introduce the concept of a “diversification factor”, which is probably the key issue
of the article. This factor may as well be extended to a cluster of “impacting signals”, which may fit the
modern definition of epigenetics, encompassing signals defined as “epigenators”, “initiators” and
“maintainers”, of which transcription factors (TFs), microRNAs and histone modifying enzymes (like
histone deacetylases = HDACS) are known to play important parts, since they constitute a strongly
interwoven network with feed-forward- and feed-back regulatory loops.
This network is under the influence of environmental/positional “factors” (epigenators, e.g. surface
molecules, mechanical stimulation, environmental chemicals and others) recognized by the
“initiators/maintainers” (e.g. TFs and microRNAs), and most importantly, this regulatory web is common to
embryonic cells, stem cells, cancer stem cells, and adult (i.e. differentiated) cells. It is therefore highly
probable that the degree of aneuploidy of cancer cells is highly dependent on environmental phenomena,
and not solely on intrinsic or “inherited” traits localized within the cancerous cells themselves.
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and not solely on intrinsic or “inherited” traits localized within the cancerous cells themselves.
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